Societal Cdmo Inc (SCTL)

$1.1

Market is closed - opens 7 PM, 25 Jun 2024

Highlights

Market Capitalization
116.1M
Book Value
$0.56
Earnings Per Share (EPS)
-0.14
Wall Street Target Price
1.1
Profit Margin
-14.03%
Operating Margin TTM
2.73%
Return On Assets TTM
-1.44%
Return On Equity TTM
-22.4%
Revenue TTM
94.6M
Revenue Per Share TTM
0.99
Quarterly Revenue Growth YOY
14.2%
Gross Profit TTM
23.1M
EBITDA
5.3M
Diluted Eps TTM
-0.14
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.09
EPS Estimate Next Year
-0.06
EPS Estimate Current Quarter
-0.01
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    90%Buy
    10%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Societal Cdmo Inc(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 0.0%

Current $1.10
Target $1.10

Company Financials

FY18Y/Y Change
Revenue
77.3M
↑ 7.67%
Net Income
-79.7M
↑ 59.19%
Net Profit Margin
-103.07%
↓ 33.35%
FY19Y/Y Change
Revenue
99.2M
↑ 28.28%
Net Income
-38.4M
↓ 51.79%
Net Profit Margin
-38.74%
↑ 64.33%
FY20Y/Y Change
Revenue
66.5M
↓ 32.98%
Net Income
-46.7M
↑ 21.4%
Net Profit Margin
-70.17%
↓ 31.43%
FY21Y/Y Change
Revenue
75.4M
↑ 13.33%
Net Income
-26.5M
↓ 43.2%
Net Profit Margin
-35.17%
↑ 35.0%
FY22Y/Y Change
Revenue
90.2M
↑ 19.71%
Net Income
-19.9M
↓ 24.99%
Net Profit Margin
-22.04%
↑ 13.13%
FY23Y/Y Change
Revenue
94.6M
↑ 4.9%
Net Income
-13.3M
↓ 33.23%
Net Profit Margin
-14.03%
↑ 8.01%
Q3 FY22Q/Q Change
Revenue
21.6M
↓ 6.75%
Net Income
-6.9M
↑ 5.09%
Net Profit Margin
-31.84%
↓ 3.59%
Q4 FY22Q/Q Change
Revenue
24.3M
↑ 12.46%
Net Income
-17.8M
↑ 159.65%
Net Profit Margin
-73.5%
↓ 41.66%
Q1 FY23Q/Q Change
Revenue
21.5M
↓ 11.33%
Net Income
-4.7M
↓ 73.75%
Net Profit Margin
-21.76%
↑ 51.74%
Q2 FY23Q/Q Change
Revenue
21.8M
↑ 1.26%
Net Income
-3.2M
↓ 31.43%
Net Profit Margin
-14.73%
↑ 7.03%
Q3 FY23Q/Q Change
Revenue
23.6M
↑ 8.22%
Net Income
-4.6M
↑ 42.96%
Net Profit Margin
-19.47%
↓ 4.74%
Q4 FY23Q/Q Change
Revenue
27.7M
↑ 17.5%
Net Income
-786.0K
↓ 82.88%
Net Profit Margin
-2.84%
↑ 16.63%
FY18Y/Y Change
Total Assets
155.5M
↓ 16.5%
Total Liabilities
175.0M
↑ 11.19%
FY19Y/Y Change
Total Assets
110.5M
↓ 28.96%
Total Liabilities
117.2M
↓ 33.04%
FY20Y/Y Change
Total Assets
103.4M
↓ 6.38%
Total Liabilities
117.5M
↑ 0.29%
FY21Y/Y Change
Total Assets
160.3M
↑ 55.02%
Total Liabilities
118.3M
↑ 0.63%
FY22Y/Y Change
Total Assets
157.4M
↓ 1.79%
Total Liabilities
97.6M
↓ 17.48%
FY23Y/Y Change
Total Assets
153.5M
↓ 2.52%
Total Liabilities
94.8M
↓ 2.84%
Q3 FY22Q/Q Change
Total Assets
151.3M
↓ 1.36%
Total Liabilities
116.0M
↑ 0.01%
Q4 FY22Q/Q Change
Total Assets
157.4M
↑ 4.07%
Total Liabilities
97.6M
↓ 15.91%
Q1 FY23Q/Q Change
Total Assets
149.9M
↓ 4.77%
Total Liabilities
94.0M
↓ 3.71%
Q2 FY23Q/Q Change
Total Assets
148.7M
↓ 0.8%
Total Liabilities
94.4M
↑ 0.49%
Q3 FY23Q/Q Change
Total Assets
151.5M
↑ 1.88%
Total Liabilities
93.3M
↓ 1.21%
Q4 FY23Q/Q Change
Total Assets
153.5M
↑ 1.28%
Total Liabilities
94.8M
↑ 1.65%
FY18Y/Y Change
Operating Cash Flow
-43.1M
↑ 152.99%
Investing Cash Flow
-7.1M
↓ 31.33%
Financing Cash Flow
27.7M
↑ 16.22%
FY19Y/Y Change
Operating Cash Flow
-25.5M
↓ 40.86%
Investing Cash Flow
-9.9M
↑ 39.21%
Financing Cash Flow
16.0M
↓ 42.33%
FY20Y/Y Change
Operating Cash Flow
8.1M
↓ 131.64%
Investing Cash Flow
-7.6M
↓ 22.89%
Financing Cash Flow
4.1M
↓ 74.06%
FY21Y/Y Change
Operating Cash Flow
10.9M
↑ 34.6%
Investing Cash Flow
-29.3M
↑ 285.26%
Financing Cash Flow
19.9M
↑ 379.51%
FY22Y/Y Change
Operating Cash Flow
-3.6M
↓ 133.56%
Investing Cash Flow
-8.4M
↓ 71.49%
Financing Cash Flow
1.8M
↓ 91.09%
Q3 FY22Q/Q Change
Operating Cash Flow
473.0K
↓ 75.98%
Investing Cash Flow
-2.3M
↑ 44.49%
Financing Cash Flow
-2.1M
↑ 1145.78%
Q4 FY22Q/Q Change
Operating Cash Flow
2.0M
↑ 321.56%
Investing Cash Flow
-2.7M
↑ 18.49%
Financing Cash Flow
4.2M
↓ 301.16%
Q1 FY23Q/Q Change
Operating Cash Flow
-2.9M
↓ 243.08%
Investing Cash Flow
-3.4M
↑ 23.39%
Financing Cash Flow
-2.5M
↓ 159.45%
Q2 FY23Q/Q Change
Operating Cash Flow
1.2M
↓ 142.94%
Investing Cash Flow
-2.1M
↓ 36.58%
Financing Cash Flow
-674.0K
↓ 72.75%

Technicals Summary

Sell

Neutral

Buy

Societal Cdmo Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • First Light Asset Management, LLC

    18.64%
  • Samjo Capital, LLC

    7.61%
  • Awm Investment Company Inc

    6.85%
  • Driehaus Capital Management LLC

    4.02%
  • Royce & Associates, LP

    3.12%
  • Samjo Management LLC

    2.91%

Company Information

recro gainesville, llc, provides solid dosage form development, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market. specializing in extended release solid dose and dea controlled substances, recro has the experts to deliver clients’ most complex pharmaceutical development and manufacturing projects in its best-in-class, 97,000-square-foot manufacturing facility. for more information about recro’s flexible cdmo solutions, visit www.recrogainesville.com

Organization
Societal Cdmo Inc
Employees
258
CEO
Mr. Wayne B. Weisman J.D.
Industry
Miscellaneous

FAQs